The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with the current issues and industry trends.
The Journal focuses on the commercial, legal, and regulatory issues affecting biotechnology, biopharmaceutical, agrochemical and environmental companies.
The Journal of Commercial Biotechnology is published quarterly, with issues in January, April, July, and October of each year.
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers, within this fast moving field.
Every issue of Journal of Commercial Biotechnology publishes forward-thinking regular features from some of the leading names in biotechnology commercialisation.
By subscribing to Journal of Commercial Biotechnology, you will have access to the latest intelligence on cutting-edge life science research commercialisation, worldwide:
Peer-reviewed papers - original, high-quality articles from leading practitioners on the latest thinking, developments and techniques affecting biopharmaceutical, agrochemical and environmental companies
Legal & regulatory updates - providing expert guidance on the major legal and regulatory issues affecting the industry, compiled and prepared by Bird & Bird and Reed Smith
Financial account reports - summarizing the finances of the major established and newly-formed biotech companies
Book reviews - previewing forthcoming books in life science commercialisation
The Journal of Commercial Biotechnology is essential reading for:
- Vice Presidents
- Heads of Business Development
- Heads of Corporate Development
- Commercial Directors
- Chief Financial Officers
- Investment Managers
- Heads of Corporate Intellectual Property
- Heads of Regulatory Affairs
- Intellectual Property Lawyers and all those involved in the commercialisation of biotechnology
Table of Contents Example:
Vol 22, No 2 (2016)
Of Pens, Pizzas, and Pharmaceuticals
Peter J. Pitts
Intellectual Property Business Models Using Patent Acquisition: A Case Study of Royalty Pharma Inc.
Su Young Lim, Minsuk Suh
Manage Complexity and Uncertainty in Biotechnological Innovations: Converting Theoretical Advances into Opportunities
The Chinese medical device market: Market drivers and investment prospects
Weifan Zhang, Rebecca Liu, Chris Chatwin
Investor experience in biotechnology
William Bains, Daniel Rabbie, Weiyi Yao, David Ricardo Munoz Guzman
The BIEM Verification Study: Experienced Venture Capitalists Assess a Biopharmaceuticals Innovation Expertise Model
Moira A. Gunn, Nola Masterson, Paul Lorton, Jr., Jacques Baronet
Intellectual Property Management
Recent Developments in Compulsory Licensing of Pharmaceutical Patents in India
Legal and Regulatory Updates
Post-Grant Review of U.S. Patents: A Primer
Stefan Michael Miller, Gregory R. Springsted
Technology Commercialization & Partnerships for Global Health